|
Sign In to gain access to subscriptions and/or personal tools.
|
Shaping the Intimate:
Influences on the Experience of Everyday Nerves
David Healy
University of Wales, College of Medicine, Hergest Unit, Bangor, Wales fax: +44 1248 371397Healy_Hergest{at}compuserve.com
Before 1980, most people experiencing common nervous problems and who sought medical help complained of anxiety and were treated for anxiety. Similar experiences increasingly led to complaints of or treatment for panic attacks in the late 1980s and early 1990s, and to complaints of or treatment for mood disorders by the mid-1990s. Today, such patients seem once again increasingly likely to complain of and be treated for anxiety. This paper reviews a series of mechanisms whereby company marketing can both transform the perceptions of physicians and shape the experiences of those seeking treatment and the self-understanding of those not in treatment. These include the standard ploys of company sales departments to increase demand for products, including celebrity endorsements, the sponsoring of educational events and a host of reminders. The portfolio of marketing manoeuvres has grown, though, by translating educational events and celebrity events into the arena of scientific research: clinical trials have increasingly become part of the marketing of disorders and their treatments; ghost-written scientific papers are authored by celebrity researchers. The portfolio of marketing manoeuvres has also grown to encompass new ways of creating fashion through medical activism, by setting up patient groups and disease awareness campaigns. The result is a transformation and growth in disorders tailor-made to fit ever more visible drugs.
Key Words: antidepressants • depression • ghost-writing • globalization • marketing • neurosis
Social Studies of Science, Vol. 34, No. 2,
219-245 (2004)
DOI: 10.1177/0306312704042620
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
J. Abraham and C. Davis
Drug Evaluation and the Permissive Principle: Continuities and Contradictions between Standards and Practices in Antidepressant Regulation
Social Studies of Science,
August 1, 2009;
39(4):
569 - 598.
[Abstract]
[PDF]
|
|
|
|
|
|
|
S. Sismondo
Ghosts in the Machine: Publication Planning in the Medical Sciences
Social Studies of Science,
April 1, 2009;
39(2):
171 - 198.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. Applbaum
`Consumers are Patients!' Shared Decision-making and Treatment Non-compliance as Business Opportunity
Transcultural Psychiatry,
March 1, 2009;
46(1):
107 - 130.
[Abstract]
[PDF]
|
|
|
|
|
|
|
E. Bromley and J. T. Braslow
Teaching Critical Thinking in Psychiatric Training: A Role for the Social Sciences
Am J Psychiatry,
November 1, 2008;
165(11):
1396 - 1401.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Bromley
Barriers to the Appropriate Clinical Use of Medications That Improve the Cognitive Deficits of Schizophrenia
Psychiatr Serv,
April 1, 2007;
58(4):
475 - 481.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Goven
Processes of Inclusion, Cultures of Calculation, Structures of Power: Scientific Citizenship and the Royal Commission on Genetic Modification
Science Technology Human Values,
September 1, 2006;
31(5):
565 - 598.
[Abstract]
[PDF]
|
|
|
|
|
|
|
D. HEALY, M. HARRIS, R. TRANTER, P. GUTTING, R. AUSTIN, G. JONES-EDWARDS, and A. P. ROBERTS
Lifetime suicide rates in treated schizophrenia: 1875-1924 and 1994-1998 cohorts compared
The British Journal of Psychiatry,
March 1, 2006;
188(3):
223 - 228.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Sismondo
Pharmaceutical Maneuvers
Social Studies of Science,
April 1, 2004;
34(2):
149 - 159.
[PDF]
|
|
|
|
|
